article thumbnail

Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease

Cardiovascular Diabetology

Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Information on GLD (dispended 6 months before or after coronary angiography) was collected from the Swedish Prescribed Drug Registry.

article thumbnail

Safe Deferral of Coronary Computed Tomography Angiography for Patients With a Low Pretest Probability of Coronary Artery Disease in 2019 European Society of Cardiology Guidelines

Journal of the American Heart Association

BackgroundCoronary computed tomography angiography is increasingly used as the firstā€line test for suspected coronary artery disease. PTP was calculated according to the 2013 and 2019 ESC guidelines. Updated 2019 ESC guidelines classified 72% of the patients as having low PTP, whose imaging could have been deferred.

article thumbnail

7 Things You Can Do To Reduce Your Risk Even If You Already Have Heart Disease.

Dr. Paddy Barrett

A common feedback I get is that people with existing coronary artery disease feel like it doesn’t apply to them. Arguably, applying the principles of prevention offers more bang for buck in the short term for people WITH coronary artery disease than those without coronary artery disease.

article thumbnail

Use of downstream stress imaging tests for risk stratification of patients presenting to the emergency department with chest pain and low HEART score

Open Heart

Methods We prospectively included 1384 patients with LRHSs between March 2019 and March 2021. The primary endpoints included cardiac death, non-fatal myocardial infarction and unplanned coronary revascularisation. All the patients underwent NISI (involving myocardial perfusion imaging/stress echocardiography).

article thumbnail

Association Between Coronary Assessment in Heart Failure and Clinical Outcomes Within a Safety-Net Setting Using a Target Trial Emulation Observational Design

Circulation: Cardiovascular Quality & Outcomes

There are no randomized clinical trials of coronary assessment after HF diagnosis.METHODS:Using an electronic health record cohort of all individuals with HF within the San Francisco Health Network from 2001 to 2019, we identified factors associated with coronary assessment.

article thumbnail

Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE?BMT Risk Score

Journal of the American Heart Association

The risk score included age, transplant type, race, coronary artery disease, heart failure, peripheral artery disease, creatinine, triglycerides, and prior anthracycline dose. The score was externally validated in a separate cohort of 919 HSCT recipients (mean age at transplant 54 years; 20.4%

article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3